Stryker's strong sales are threatening Zimmer Biomet's market share in the medical device sector.
1 report, 1 independent
Updated Aug 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Stryker's strong sales are threatening Zimmer Biomet's market share in the medical device sector.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Zimmer Biomet Holdings is leveraging clinical expertise to influence its product pipeline and challenge the core orthopedics and robotics market.Also in this story
- Gary Campbell was promoted to President, Americas, and Kessler was promoted to President, Americas – Robotics.
- Pro-Dex pitch is tied to Zimmer's mBos robot commercialization, following Zimmer's acquisition of Monogram Technologies.
- Matson maintained a neutral stance on Zimmer Biomet Holdings stock, noting the influence of ZBH's acquisition strategy on analyst outlook.
The entities involved
-
Zimmer Biomet Holdings
medical device company
Nothing else this week.
-
Stryker (Canada)
Nothing else this week.
Coverage
Newest first; wire copies grouped- Medical Device NetworkStryker may be able to displace Zimmer in US knee reconstruction market In the second quarter (Q2) of 2025, the knee reconstruction market brought in more than $400 million to the US. Zimmer Biomet c